Clinical Trial Update: Evolocumab Plus Ezetimibe in Haemodialized Statin-intolerant Patients With Hypercholesterolemia [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating evolocumab plus ezetimibe in statin-intolerant patients with hypercholesterolemia undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease Requiring Chronic Dialysis
• Chronic Kidney Disease Stage
• Hypercholesterolemia

Drugs mentioned

• EZETIMIBE (EZETIMIBE)
• Evolocumab (evolocumab)

Snippet

Sponsor: Policlinico Casilino ASL RMB | Conditions: Hypercholesterolemia, CKD Stage 5 | Phase 4 | Status: UNKNOWN